Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess pre- and postoperative neuropathic pain in patients with traumatic brachial plexus injuries to determine if intraoperative ketamine infusion affect neuropathic pain associated with avulsion injuries of the brachial plexus.


Clinical Trial Description

Neuropathic pain following traumatic brachial plexus injuries is a common and debilitating problem that has been reported in up to 64-75% of patients. Neuropathic pain is difficult to treat, particularly when secondary to avulsion injuries of the brachial plexus. Current treatment options include neuromodulating pharmacologic agents including gabapentin, pregabalin, tricyclic antidepressants, and duloxetine among others. Other analgesic modalities include TENS unit application, massage, acupuncture, and topical medications. Despite these treatment options, patients frequently continue to experience significant, debilitating neuropathic pain. The use of ketamine has recently been studied in complex regional pain syndrome (CRPS), spinal cord injuries, and chronic neuropathic pain with encouraging results. Ketamine is thought to exert its analgesic properties via noncompetitive central nervous system N-methyl-D-aspartate (NMDA) antagonism among other primarily central mechanisms including sodium channel blockade, activation of D2 dopamine receptors and facilitation of γ-aminobutyric acid A (GABA-A) signaling. It is utilized clinically in acute and chronic pain management primarily in hospitalized settings to treat a variety of pain states as well as medically refractory depression and headache disorders. The dosing and administration of ketamine infusion varies widely across studies and includes oral ketamine, low dose infusions, and infusions producing an anesthetic effect. To our knowledge, ketamine's use in subanesthetic doses has not been adequately evaluated in patients with neuropathic pain following traumatic brachial plexus injuries. Our study aims to determine how intraoperative ketamine infusion alters neuropathic pain severity associated with brachial plexus avulsion injury in the post-operative period. In addition, we hypothesize that patients receiving intraoperative ketamine infusion will require less narcotic pain medication through the follow-up period of 6 months following surgery. Patients who are undergoing planned surgery for brachial plexus reconstruction at Mayo Clinic will be enrolled into this study to be randomized into getting ketamine infusions or a placebo medication during surgery and in the 24 hour postoperative period after surgery. Pain will be measured before surgery and at various time points to up to 6 months after surgery through online pain measurement scores. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04933149
Study type Interventional
Source Mayo Clinic
Contact
Status Enrolling by invitation
Phase Phase 4
Start date December 15, 2021
Completion date June 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05859178 - Exercise Training for Brachial Plexus Injury Following Nerve Transfer Phase 2
Completed NCT05575674 - Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes
Enrolling by invitation NCT06437990 - Arteriovenous Loop Graft for Free Functional Gracilis Transfer in Brachial Plexus Surgery N/A
Completed NCT01393444 - ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis N/A
Active, not recruiting NCT04900896 - Outcome Measures Study on an Adult Myoelectric Elbow-Wrist-Hand Orthosis
Terminated NCT01297439 - New Prophylactic Maneuver: the "Pushing" Maneuver, Aiming to Reduce the Risk for Shoulder Dystocia N/A
Completed NCT06237270 - External Validation Study for Risk Prediction Model for Unsuccessful Elbow Flexion Recovery After Nerve Transfer Surgery in Patients With Brachial Plexus Injury
Recruiting NCT06313658 - Enhancing Functional Hand Recovery Through Nerve Reconstruction in Total Brachial Plexus Birth Injury
Not yet recruiting NCT05810077 - Feasibility of Brachial Plexus Ultrasound in Evaluation of Patients With Brachial Plexus Injuries
Not yet recruiting NCT04959058 - EVALUATION OF BRACHIAL PLEXUS IN DIFFERENT ARM POSITION N/A
Recruiting NCT04939233 - Robotic Hand Orthosis Providing Grasp Assistance for Patients With Brachial Plexus Injuries N/A
Recruiting NCT00755586 - Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm Phase 1/Phase 2
Completed NCT03377712 - Surgical Repercussions in Respiratory System in Patients With Post-Traumatic Brachial Plexus Injuries: A Prospective Cohort Study
Completed NCT03409536 - Somatosensory Evoked Potential (SSEP) Monitoring for Brachial Plexus Injury
Completed NCT03162393 - The Surgical Treatment of Total Brachial Plexus Avulsion Injury-A Retrospective Study of 73 Patients N/A
Recruiting NCT04733599 - Neurostimulation for Treatment of Chronic Upper Limb Pain After Brachial Plexus Injury
Recruiting NCT01894802 - Cortical Recording and Stimulating Array Brain-Machine Interface N/A
Completed NCT02711774 - Changes in Optic Nerve Sheath Diameter in Response to Various Levels of End Tidal Carbon Dioxide Levels N/A
Recruiting NCT05693038 - Brachial Plexus Injury After Prone Positioning
Withdrawn NCT01334632 - Incidence of Brachial Plexus Injury After Rotator Cuff Repair With Continuous Interscalene Block N/A